We have previously reported on the basic (by 35%) and SC-52458 was still measurable in plasma from treated dogs. In dogs made pharmacologic properties of SC-52458 (5-[(3,5-hypertensive by constriction of the left renal artery, dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(1H-SC-52458 lowered mean arterial pressure compared tetrazol-5-ylphenyl)]pyridine), a novel angiotensin to vehicle treatment although heart rate was not (AII) receptor antagonist that binds potently to AT 1 different in the two groups. The maximal blood receptors in rat adrenal cortex and blocks AIIpressure lowering achieved with SC-52458 was mediated contraction in isolated rabbit aorta. In the similar to the maximal effect observed with the present study, the ability of SC-52458 to block AII angiotensin converting enzyme inhibitor lisinopril. pressor responses in conscious dogs was measured.
I
angiotensin I ( AI ) by the enzyme renin is the rate limiting step in the production of AII and is the only known function of renin, whereas angiotensin converting enzyme ( ACE ) is known to act on a number nhibition of the renin-angiotensin system with converting enzyme inhibitors is an effective mode of treatment for essential hypertension and congestive heart failure.
2, 3 The antihypertensive mechanism underlying converting enzyme inhibition of other biologically active peptides. 5 Specifically, it has been proposed that part of the antihypertensive is presumably prevention of the production of angiotensin II ( AII ) . 4 The conversion of angiotensinogen to activity of the ACE inhibitors might be due to potentiation of bradykinin effects. 6 Thus, blockade of angiotensin II receptors may lead to highly specific antihypertensive agents with an improved side effect profile tagonist that provides a useful tool for addressing this question in an established, renin-dependent form of hypertension, the 2 kidney / 1 clip renal hypertensive dog. 7 Although others have shown that acute administration of an AT 1 receptor antagonist ( SK&F 108566 ) and an ACE inhibitor ( enalapril ) lower blood pressure comparably when administered acutely to renal hypertensive dogs, 8 chronic dosing in this model has not been reported with either AT 1 receptor antagonists or ACE inhibitors. In addition, all previous studies have compared only single doses of AII receptor antagonists and ACE inhibitors that severely limits interpretation of these comparative data.
We have reported previously that SC-52458 is a po-FIGURE 1.
SC-52458,5-[ ( 3,5-dibutyl-1H-1,2,4-triazol-1-yl )-methyl ] -2-[ 2-( 1H-tetrazol-5-ylphenyl ) ] pyridine.
tent, competitive, reversible antagonist of angiotensin II AT1 type vascular receptors with a pA 2 of 8.18 in isolated rabbit aorta. 1 Moreover, SC-52458 is a potent h after administration of SC-52458 or placebo. Blood hypotensive agent when administered to hypertensamples were drawn just before administration of the sive rats ( spontaneously hypertensive and renal hy-AII boluses. After the 8-h time point, the dogs were pertensive ) and sodium-deficient dogs. In the present disconnected from the blood pressure transducer, their study we used SC-52458 to test the hypothesis that intravenous catheters were removed, and they were rechronic AII receptor blockade would be efficacious in turned to their home cages and allowed food and water a renin-dependent model of hypertension in the dog.
ad libitum. The next morning the dogs were returned Our results indicate that AII receptor blockade with to the slings, the arterial line was reconnected, and a SC-52458 is highly effective at lowering blood presnew intravenous catheter was inserted to allow for a 24-sure in renal hypertensive dogs. This work has been h blood sample and recording of the pressor response to reported previously in abstract form. 9 injection of AII.
METHODS
Quantitative Analysis of SC-52458 in Plasma Plasma concentrations of SC-52458 were determined using the Angiotensin II Pressor Assay in Dog Animal Preparation Female mongrel dogs ( 9 to 13 kg; Hazelton, Cum-assay procedure described previously. 1 An aliquot ( 0.1 to 0.2 mL ) of plasma sample was mixed with 0.1 mL berland, VA ) were anesthetized with isoflurane ( Anaquest, Madison, WI ) and were instrumented with a vas-of internal standard solution. The mixture was acidified with 0.1 N H 3 PO 4 to pH 3 and placed on a 1-mL CN cular access port ( 0.04 in. 1 0.09 in.) ( Access Technologies, Skokie, IL ) in the right carotid artery. Bond Elut column ( Varian Harbor, CA ) that was preactivated with methanol, distilled water, and water acidiFive days after recovery from the surgical procedure, the dogs were fasted overnight and the next morning fied to pH 3. The column containing the sample was washed with 1 mL of water at pH 3 and 0.5 mL of a the animals were placed in slings. The arterial port was connected to a Gould ( Cleveland, OH ) recorder for solvent mixture of methanol and water at pH 3 ( 20:80 vol / vol ) . SC-52458 and internal standard that were reblood pressure monitoring via a Statham transducer ( model P23ID, Oxnard, CA ) . An intravenous catheter tained on the column were eluted with 0.3 mL of a mixture of acetonitrile and 0.1% triethylamine at pH 3 was placed in the cephalic vein for administration of AII and blood sampling. After the blood pressure stabi-( 1:1 vol / vol ) . An aliquot ( 75 mL) of the eluate was injected onto an HPLC system. lized, an AII bolus ( 50 ng / kg intravenously; Sigma Chemical Co., St. Louis, MO ) was given every 5 to 10 HPLC was performed with a UV detector at a fixed wavelength of 234 nm and a NOVA PAK column ( 15 min until three similar pressor responses were obtained. The average of these three responses was con-cm 1 3.9 mm, 4 mm) with a RP-18 New Guard Cartridge (15 mm 1 3.2 mm, 7 mm). The mobile phase was a sidered 100% and all subsequent responses to AII were normalized to this response. mixture of 0.1% triethylamine in acidified water ( pH 3 ) and acetonitrile ( 62:38 vol / vol ) . The flow rate of the SC-52458 ( Figure 1 ) was given by mouth in a gelatin capsule ( 30 mg / kg ) whereas control animals received mobile phase was 1 mL /min. The sensitivity of the assay is 0.100 mg SC-52458 /mL. Acceptable precision a capsule containing lactose ( 30 mg / kg ) . Blood samples ( 2.5 mL in EDTA ) were taken at 0.25, 0.5, 1, 2, 4, and accuracy were obtained for concentrations above the sensitivity limit and within the standard curve 6, 8, and 24 h after administration of SC-52458. AII boluses were given at 0. 
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05-06-97 10:59:59 eajhas EL: AJH Two Kidney/One Clip Renal Hypertensive Dog Ani-Dickinson, Rutherford, NJ ) and the blood was centrifuged at 4000 g for 10 min at 4ЊC to separate plasma mal Preparation Female beagle dogs ( 7 to 12 kg ) were obtained from Hazelton, ( Cumberland, VA ) . Under from packed cells. Plasma samples ( 200 mL) were analyzed for plasma renin activity ( PRA ) using the method sterile conditions, the animals were anesthetized with isoflurane ( Anaquest Inc., Madison, WI ) and a catheter of Sealey and Laragh 10 with modifications. The 200-mL plasma samples were incubated with 3 mL of 0.5 mol / connected to a radiotelemetry blood pressure transmitter ( Mini-Mitter Co., Inc., Sunriver, OR ) was implanted L 8-hydroxyquinoline ( Aldrich Chemical Co., Milwaukee, WI ) , 3 mL of 10% neomycin sulfate ( Sigma ) , 1 mL in the left femoral artery. The transmitter capsule was anchored subcutaneously to the abdominal region and of phenylmethylsulfonylfluoride ( Calbiochem, La Jolla, CA ) , and 20 mL of 0.5 TES buffer ( Sigma ) at pH 7.4 at the incision was closed. After recovery from the anesthesia, the animals were returned to their home cages. 37ЊC for 90 min. The reaction was terminated by placing the mixture tubes in an ice bath. The amount of AI A receiver ( Data Sciences, Inc., St. Paul, MN ) under the dog's cage was used to collect mean arterial pressure generated was determined by an AI radioimmunoassay ( Dupont-NEN, Boston, MA ) and was expressed as na-( MAP ) and heart rate ( HR ) values every 5 min. A Compaq 486 computer ( Compaq Computer Corp., Houston, nograms of angiotensin I per milliliter of plasma per hour. TX ) was used to process the data using DataQuest IV 2.0 ( Data Sciences, Inc., St. Paul, MN ) . Six-or 24-h Statistical Analysis All statistical calculations were averages were calculated using this system. performed using SAS ( SAS Institute, Cary, NC ) . A Approximately 1 week after telemetry unit implantamean comparison resulting in a P value of .05 or less tion, the animals were anesthetized with isoflurane and was considered statistically significant. under sterile conditions, a left flank incision was made.
For inhibition of the AII pressor response, a two-way An electromagnetic flowmeter ( Carolina Medical Elec-( treatment group by time point ) , repeated measures tronics, Inc., King, NC ) was placed around the left renal ( on time point ) ANOVA was performed. The means at artery to record blood flow. A 3-mm stainless steel each time point were tested for significant differences Goldblatt clamp ( Keystone Automation Technology, from 100% control ( same as initial values ) . For the Emporium, PA ) was then placed around the left renal plasma levels of SC-52458, a one-way, repeated meaartery and tightened to reduce blood flow by 70% to sures ANOVA was performed to compare the means 80%. The clamp was tightened until the reduction in across time points. flow was maintained for at least 15 min. The screw of For the renal hypertensive dog study, comparison of the clamp was then secured with cyanoacrylate glue the PRA and MAP for the SC-52458 group and the and the flank incision was closed. Before clamping, a lisinopril group was performed using a one-way AN-3-mL blood sample was obtained and 4 days after con-OVA. The analysis was conducted both on the poststriction of the left renal artery, a second 3-mL sample clip values and on the change from pre-clip to postwas obtained for measurement of plasma renin activity clip values. The analysis on the change variable also ( PRA ) ( see Method section below ) . Dogs with mean allowed tests of significant difference from pre-to postarterial pressure that increased less than 25 mm Hg on clip for each group by testing for significant differences day 5 after renal artery constriction or animals with from zero. PRA that increased less than twofold on day 4 after Because of the circadian pattern of HR and blood renal artery constriction were removed from further pressure ( values highest at mid-morning and then destudy. Using these criteria, three dogs were eliminated creasing during the evening and at night ) , daily averfrom the study. SC-52458 was dissolved in 1 N NaOH ages of these parameters were computed and comand then 0.1 N HCl was added slowly to adjust the pH pared. The analysis was performed on the change in to approximately 9.5. Distilled water was added to a HR and blood pressure from day 0 to days 1, 2, 3, and final concentration of 75 mg /mL. The compound was 4. PROC MIXED in SAS was used to perform the twoadministered at 10, 30, or 60 mg / kg loaded into a gelaway ( treatment group by day ) , repeated measures ANtin capsule daily at 12:30 PM for 4 days, beginning 6
OVA. The t test means comparisons were made to the days after renal artery constriction. Vehicle-treated anivehicle group. Means averaged over all 4 days were mals received capsules containing distilled water adcompared if the analysis found no significant difference justed to pH 9.5 with 1 N NaOH. In separate experiin the pattern of mean differences over days ( P value ments, lisinopril ( U.S.P.C., Rockville, MD ) was adminfor interaction ú.10). istered in a gelatin capsule to renal hypertensive dogs at 12:30 PM for 4 days, beginning 6 days after renal RESULTS artery constriction.
Angiotensin II Pressor Assay in Dog The AII pressor Plasma Renin Activity A 3-mL blood sample was collected in EDTA-containing Vacutainer tubes ( Becton response was inhibited by approximately 60% within 1 / 2e17$$2201 05-06-97 10:59:59 eajhas EL: AJH sensitive analysis, the ANOVA calculations were conducted on the change in MAP and HR for each dog from day 0. As shown in Figure 4A , SC-52458 lowered MAP each day in a dose-dependent manner compared to the vehicle. The pattern of differences between means was not significantly different over days ( interaction P value ú.10). The drop in MAP was consistent over time, averaging 4.0, 11.9, and 16.4 mm Hg in the SC-52458 groups at 10, 30, and 60 mg / kg, respectively, compared to 3.3 mm Hg in the vehicle group ( all means averaged over the 4 treatment days ) . These reductions in MAP were significantly different from the vehicle mean at the 30-and 60-mg / kg doses of SC-52458. For SC-52458 at 30 and 60 mg / kg, the mean change in MAP was significantly less than zero on each of the treatment days, indicating sustained blood pressure lowering effects over the 4 days of treatment, the decrease in MAP with lisinopril at 1 and 3 mg / kg ( 14.6 and 24.2 mm Hg ) was significantly different from vehicle ( 3.3 mm Hg ) . h after oral administration of SC-52458 at 30 mg / kg, The mean for lisinopril at 3 mg / kg is significantly difand maximal inhibition ( 91% ) was obtained 2 h after dosing with SC-52458 ( Figure 2 ) . For the SC-52458 group, the AII pressor response was significantly reduced from the pretreatment value at every time point. This includes the 24-h time point at which the pressor response was inhibited 35%. For the placebo group, the AII pressor response had returned to within 10% of the pretreatment value at the 24-h time point, a nonsignificant difference.
Plasma concentrations of SC-52458 were significantly higher at 2 h after SC-52458 administration ( 9.74 { 1.24 mg/mL) than at any other time point. SC-52458 was still measurable in plasma 24 h after dosing ( 0.29 { 0.09 mg/mL) ( Figure 3 ) . The Spearman correlation coefficient indicated a statistically significant negative relationship between the plasma level and the AII pressor response ( rs Å 0.93, P Å 0.0025 ) .
Two Kidney/One Clip Renal Hypertensive Dog
There were no significant differences between the six treatment groups in PRA and MAP post-clip values or in the amount of change from pre-clip to post-clip values ( Table 1 ) . In all cases, the post-clip values were FIGURE 3. Plasma concentrations of SC-52458 in conscious significantly elevated. ferent from the means for lisinopril at 1 mg / kg and tive blocker of the AII pressor response in conscious, normotensive dogs dosed with the compound at 30 for SC-52458 at 30 mg / kg, but was not statistically different from SC-52458 at 60 mg / kg. mg / kg. Blockade of the pressor response to an AII challenge correlated well with the quantity of SCAs shown in Figures 4B and 5B, the circadian pattern of HR was more prominent than the circadian variation 52458 measured in plasma. Even 24 h after a single dose of SC-52458, the pressor response to AII was in blood pressure, with heart rates highest at mid-morning, decreasing during the rest of the day, and reaching still inhibited by 35%. These properties of SC-52458 suggested to us that SC-52458 might be an effective the lowest value at night. The pattern of differences between means was not significantly different over antihypertensive agent when dosed chronically in a hypertensive animal model and therefore, we studied days ( interaction P value ú.10). When averaged over the 4-day treatment period, there were no statistically SC-52458 in the 2 kidney / 1 clip renal hypertensive dog. significant differences between any of the treatment group means and the mean for the vehicle group.
Renal artery constriction in dogs results in a reninTherefore, both SC-52458 and lisinopril decreased MAP dependent hypertension, although the renin depenin a significant and similar manner with no evidence dency of the hypertension is transient and often variof reflex tachycardia when compared to the vehicle-able. 7, 14 We chose to test inhibitors of the renin-angiotreated animals.
tensin system in this model from 6 to 10 days after constriction of the renal artery, a period of time when DISCUSSION both PRA and MAP are substantially elevated and reasonably stable. 15 In the present study, a telemetry Although ACE inhibitors are highly effective antihydevice was used to monitor the blood pressure and pertensive agents in most patients, these compounds HR continuously at 5-min intervals throughout the can cause serious side effects, namely cough and dosing interval with the animals freely moving in angioedema, in some patients. 11 The mechanism of their home cages. Observations from the vehiclethese side effects is believed to be potentiation of bratreated group indicate that a prominent circadian patdykinin effects by inhibition of ACE ( also known as tern of blood pressure variation is present in the 2 kininase II ) , the enzyme responsible for the degradakidney / 1 clip hypertensive dogs, which is similar to tion of bradykinin. In addition, numerous reports the profile in hypertensive patients. 16 Blood pressure have now demonstrated that AII can be formed, at was highest in the morning and reached its nadir each least in human heart, by a chymotrypsin-like enzyme night. Both SC-52458 and lisinopril produced a sigor chymase that is not blocked by ACE inhibitors. 12 nificant reduction in MAP in the hypertensive dogs Thus, AT 1 receptor blockers may have an improved and the same maximal decrease was observed with side effect profile and could be more efficacious durboth compounds. Previous data from our laboratory ing long-term use than ACE inhibitors. Preliminary indicated that 3 mg / kg of lisinopril was a maximal data with the first AT 1 receptor antagonist available dose for blood pressure lowering in the salt-depleted for human use, losartan, indicates that these comdog ( unpublished observations ) . Therefore, these pounds may offer therapeutic advantages over exdata suggest that the blood pressure reduction in this isting therapies. 13 As demonstrated in this study, SC-52458 is an effec-model is most likely attributable to inhibition of the / 2e17$$2201 05-06-97 10:59:59 eajhas EL: AJH renin-angiotensin system and not other effects of the ACE inhibitors such as bradykinin potentiation. This conclusion is supported by the fact that renin inhibitors produce a similar maximal decrease in blood pressure in this model. 17 As reported previously for renin inhibitors and ACE inhibitors in salt-depleted and renal hypertensive animals, SC-52458 and lisinopril lowered MAP effectively in the 2 kidney / 1 clip hypertensive dog without any significant reflex tachycardia. Our study is particularly powerful in confirming these previous observations, as our measurements were obtained in dogs freely moving in their home cages using a radio- telemetric method rather than under conditions of stressful restraint. This lack of reflex tachycardia associated with inhibition of the renin-angiotensin system is believed to be due to removal of an AII potentiation of baroreflexes, although no conclusive evidence is FIGURE 4. Effect of oral administration of SC-52458 and ve-available in support of this hypothesis. However, this hicle on ( A) mean arterial pressure ( MAP ) and ( B) heart rate lack of reflex tachycardia is a clear advantage of using in 2 kidney / 1 clip renal hypertensive dogs with implanted radiote-renin-angiotensin system inhibitors rather than other lemetry transmitters for continuous measurement of blood presantihypertensive agents that tend to increase HR in sure and heart rate. Dosing was initiated 6 days after renal artery response to a decrease in blood pressure. 
